Histoplasma capsulatum modulates the immune response, affects proliferation and differentiation, and induces

Carolina Rodríguez-Echeverri1, Beatriz L Gómez2, Ángel González1

  • 1Basic and Applied Microbiology Group (MICROBA), School of Microbiology, Universidad de Antioquia, Medellín, Colombia.

Mycoses
|October 11, 2022
PubMed

Insights

Infection of mesenchymal stromal cells (MSCs) by Histoplasma capsulatum impairs their viability and differentiation. These findings reveal how fungal pathogens impact MSC function and host immunity.

Area of Science:

  • Immunology
  • Cell Biology
  • Mycology

Background:

  • Mesenchymal stromal cells (MSCs) are vital for tissue repair and immune modulation.
  • Pathogen infection can compromise MSC functions, including proliferation and differentiation.
  • Understanding MSC responses to fungal invasion is crucial for disease treatment.

Purpose of the Study:

  • To investigate the effects of Histoplasma capsulatum yeast infection on bone marrow-derived MSCs.
  • To determine if fungal infection impacts MSC activation, differentiation, and proliferation.

Main Methods:

  • Infection of bone marrow-derived MSCs with Histoplasma capsulatum yeasts.
  • Analysis of MSC phagocytosis, antifungal activity, and inflammatory mediator expression.
  • Assessment of MSC viability and differentiation capacity post-infection.

Main Results:

  • MSCs phagocytose H. capsulatum yeasts but show limited antifungal activity.
  • Fungal infection modulates inflammatory mediator expression via TLR2, TLR4, and Dectin-1 pathways.
  • MSC viability and differentiation capacity are significantly affected by H. capsulatum infection.

Conclusions:

  • MSC infection by H. capsulatum impairs their function and viability.
  • Infected MSCs may influence hematopoiesis and host immune responses.
  • MSCs can serve as a niche for H. capsulatum, promoting fungal persistence and immune evasion.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.9K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.2K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
69.8K